Literature DB >> 30359189

Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.

Matthew R Detter1,2, Daniel A Snellings1, Douglas A Marchuk1.   

Abstract

RATIONALE: Vascular malformations arise in vessels throughout the entire body. Causative genetic mutations have been identified for many of these diseases; however, little is known about the mutant cell lineage within these malformations.
OBJECTIVE: We utilize an inducible mouse model of cerebral cavernous malformations (CCMs) coupled with a multicolor fluorescent reporter to visualize the contribution of mutant endothelial cells (ECs) to the malformation. METHODS AND
RESULTS: We combined a Ccm3 mouse model with the confetti fluorescent reporter to simultaneously delete Ccm3 and label the mutant EC with 1 of 4 possible colors. We acquired Z-series confocal images from serial brain sections and created 3-dimensional reconstructions of entire CCMs to visualize mutant ECs during CCM development. We observed a pronounced pattern of CCMs lined with mutant ECs labeled with a single confetti color (n=42). The close 3-dimensional distribution, as determined by the nearest neighbor analysis, of the clonally dominant ECs within the CCM was statistically different than the background confetti labeling of ECs in non-CCM control brain slices as well as a computer simulation ( P<0.001). Many of the small (<100 μm diameter) CCMs consisted, almost exclusively, of the clonally dominant mutant ECs labeled with the same confetti color, whereas the large (>100 μm diameter) CCMs contained both the clonally dominant mutant cells and wild-type ECs. We propose of model of CCM development in which an EC acquires a second somatic mutation, undergoes clonal expansion to initiate CCM formation, and then incorporates neighboring wild-type ECs to increase the size of the malformation.
CONCLUSIONS: This is the first study to visualize, with single-cell resolution, the clonal expansion of mutant ECs within CCMs. The incorporation of wild-type ECs into the growing malformation presents another series of cellular events whose elucidation would enhance our understanding of CCMs and may provide novel therapeutic opportunities.

Entities:  

Keywords:  cell lineage; cerebral cavernous malformations; cerebrovascular disease; genetics; mutation; vascular malformation

Mesh:

Substances:

Year:  2018        PMID: 30359189      PMCID: PMC6205520          DOI: 10.1161/CIRCRESAHA.118.313970

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  31 in total

1.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

2.  Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development.

Authors:  Yun He; Haifeng Zhang; Luyang Yu; Murat Gunel; Titus J Boggon; Hong Chen; Wang Min
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

3.  EndMT contributes to the onset and progression of cerebral cavernous malformations.

Authors:  Luigi Maddaluno; Noemi Rudini; Roberto Cuttano; Luca Bravi; Costanza Giampietro; Monica Corada; Luca Ferrarini; Fabrizio Orsenigo; Eleanna Papa; Gwenola Boulday; Elisabeth Tournier-Lasserve; Françoise Chapon; Cristina Richichi; Saverio Francesco Retta; Maria Grazia Lampugnani; Elisabetta Dejana
Journal:  Nature       Date:  2013-06-09       Impact factor: 49.962

4.  Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology.

Authors:  Angeliki Louvi; Leiling Chen; Aimee M Two; Haifeng Zhang; Wang Min; Murat Günel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

5.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

6.  Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.

Authors:  Judith Gault; Issam A Awad; Peter Recksiek; Robert Shenkar; Robert Breeze; Michael Handler; Bette K Kleinschmidt-DeMasters
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

7.  Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.

Authors:  Amy L Akers; Eric Johnson; Gary K Steinberg; Joseph M Zabramski; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

10.  Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice.

Authors:  Luca Bravi; Noemi Rudini; Roberto Cuttano; Costanza Giampietro; Luigi Maddaluno; Luca Ferrarini; Ralf H Adams; Monica Corada; Gwenola Boulday; Elizabeth Tournier-Lasserve; Elisabetta Dejana; Maria Grazia Lampugnani
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-24       Impact factor: 11.205

View more
  31 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.

Authors:  Daniel A Snellings; Carol J Gallione; Dewi S Clark; Nicholas T Vozoris; Marie E Faughnan; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2019-10-17       Impact factor: 11.025

3.  CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling.

Authors:  Lingfeng Qin; Haifeng Zhang; Busu Li; Quan Jiang; Francesc Lopez; Wang Min; Jenny Huanjiao Zhou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-21       Impact factor: 8.311

4.  Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations.

Authors:  Matthieu Peyre; Danielle Miyagishima; Franck Bielle; Françoise Chapon; Michael Sierant; Quitterie Venot; Julie Lerond; Pauline Marijon; Samiya Abi-Jaoude; Tuan Le Van; Karim Labreche; Richard Houlston; Maxime Faisant; Stéphane Clémenceau; Anne-Laure Boch; Aurelien Nouet; Alexandre Carpentier; Julien Boetto; Angeliki Louvi; Michel Kalamarides
Journal:  N Engl J Med       Date:  2021-09-09       Impact factor: 91.245

5.  CCM2-deficient endothelial cells undergo a ROCK-dependent reprogramming into senescence-associated secretory phenotype.

Authors:  Corinne Albiges-Rizo; Hans Van Oosterwyck; Eva Faurobert; Daphné Raphaëlle Vannier; Apeksha Shapeti; Florent Chuffart; Emmanuelle Planus; Sandra Manet; Paul Rivier; Olivier Destaing
Journal:  Angiogenesis       Date:  2021-08-03       Impact factor: 9.596

6.  PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.

Authors:  Aileen A Ren; Daniel A Snellings; Yourong S Su; Courtney C Hong; Marco Castro; Alan T Tang; Matthew R Detter; Nicholas Hobson; Romuald Girard; Sharbel Romanos; Rhonda Lightle; Thomas Moore; Robert Shenkar; Christian Benavides; M Makenzie Beaman; Helge Müller-Fielitz; Mei Chen; Patricia Mericko; Jisheng Yang; Derek C Sung; Michael T Lawton; J Michael Ruppert; Markus Schwaninger; Jakob Körbelin; Michael Potente; Issam A Awad; Douglas A Marchuk; Mark L Kahn
Journal:  Nature       Date:  2021-04-28       Impact factor: 49.962

7.  Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.

Authors:  Wenqing Li; Virginia Tran; Iftach Shaked; Belinda Xue; Thomas Moore; Rhonda Lightle; David Kleinfeld; Issam A Awad; Mark H Ginsberg
Journal:  Elife       Date:  2021-05-20       Impact factor: 8.140

8.  Endothelial k-RasV12 Expression Induces Capillary Deficiency Attributable to Marked Tube Network Expansion Coupled to Reduced Pericytes and Basement Membranes.

Authors:  Zheying Sun; Scott S Kemp; Prisca K Lin; Kalia N Aguera; George E Davis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-12-09       Impact factor: 8.311

Review 9.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

10.  Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.

Authors:  Miguel Alejandro Lopez-Ramirez; Catherine Chinhchu Lai; Shady Ibrahim Soliman; Preston Hale; Angela Pham; Esau J Estrada; Sara McCurdy; Romuald Girard; Riya Verma; Thomas Moore; Rhonda Lightle; Nicholas Hobson; Robert Shenkar; Orit Poulsen; Gabriel G Haddad; Richard Daneman; Brendan Gongol; Hao Sun; Frederic Lagarrigue; Issam A Awad; Mark H Ginsberg
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.